ExLibris header image
SFX Logo
Title: PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Pfeifer, M yr:2013


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Mitrovic, Z. "CD43 expression is associated with inferior survival in the non-germinal centre B-cell subgroup of diffuse large B-cell lymphoma." British journal of haematology (2013). Link to Full Text for this item Link to SFX for this item
2. Staudt, Louis M. "Targeting pathological B cell receptor signalling in lymphoid malignancies." Nature reviews. Drug discovery 12.3 (2013): 229-243. Link to SFX for this item
3. Provencio, M. "Caspase 3a: new prognostic marker for diffuse large B-cell lymphoma in the rituximab era." Leukemia & lymphoma 51.11 (2010): 2021-2030. Link to SFX for this item
4. Bunney, Tom D. "Phosphoinositide signalling in cancer: beyond PI3K and PTEN." Nature Reviews. Cancer 10.5 (2010): 342-352. Link to SFX for this item
5. Goya, R. "Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin." Nature Genetics 42.2 (2010): 181-185. Link to SFX for this item
6. Engelman, Jeffrey A. "Targeting PI3K signalling in cancer: Opportunities, challenges and limitations." Nature Reviews. Cancer 9.8 (2009): 550-562. Link to Full Text for this item Link to SFX for this item
7. Davis, Vu E. "Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma." Nature 463.7277 (2010): 88-92. Link to Full Text for this item Link to SFX for this item
8. Nikoloski, G. "Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes." Nature Genetics 42.8 (2010): 665-667. Link to SFX for this item
9. Reber, R. "Determination of the molecular subtypes of diffuse large B-cell lymphomas using immunohistochemistry: a case series from the Inselspital, Bern, and a critical appraisal of this determination in Switzerland." Swiss medical weekly 143 (2013). Link to Full Text for this item Link to SFX for this item
10. Rickert, Robert C. "New insights into pre-BCR and BCR signalling with relevance to B cell malignancies." Nature reviews. Immunology 13.8 (2013): 578-591. Link to SFX for this item
11. Wenzel, S-S, S-S S. "MCL1 is deregulated in subgroups of diffuse large B-cell lymphoma." Leukemia 27.6 (2013): 1381-90. Link to Full Text for this item Link to SFX for this item
12. Kuittinen, R. "Cell cycle regulation score predicts relapse-free survival in non-germinal center diffuse large B-cell lymphoma patients treated by means of immunochemotherapy." European journal of haematology 91.1 (2013): 29-36. Link to Full Text for this item Link to SFX for this item
13. Laurini, Javier A. "Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases." Blood 120.24 (2012): 4795-4801. Link to SFX for this item
14. Dunn, Robert G. "Transformation from follicular lymphoma to biphasic high-grade large B-cell lymphoma with immunophenotypically and genetically distinct diffuse large B cell and Burkitt-like components." Journal of Clinical Pathology 66.4 (2013): 357-360. Link to SFX for this item
15. Buggy, J. "Bruton Tyrosine Kinase (BTK) and Its Role in B-cell Malignancy." International reviews of immunology 31.2 (2012): 119-132. Link to SFX for this item
16. Depristo, Mark A. "A framework for variation discovery and genotyping using next-generation DNA sequencing data." Nature Genetics 43.5 (2011): 491-498. Link to SFX for this item
17. Chase, A. "Aberrations of EZH2 in cancer." Clinical cancer research 17.9 (2011): 2613-2618. Link to SFX for this item
18. Witzig, Mamta E. "Signal transduction inhibitor therapy for lymphoma." Hematology 2010.1 (2010): 265-270. Link to SFX for this item
19. Dalgliesh, Gillian L. "Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes." Nature 463.7279 (2010): 360-363. Link to Full Text for this item Link to SFX for this item
20. Dedhar, S. "Integrin-linked kinase: a cancer therapeutic target unique among its ILK." Nature reviews. Cancer 5.1 (2004): 51-63. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.